Delivery Order SPE2DB24D1006-SPE2DB25FCDUQ

Award Date 10/16/24
Potential Completion Date 10/17/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award, valued at $3,394.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract to provide 4564730338 IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML to the DLA. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,951.34 Firm Fixed Price delivery order covers the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication, to support military healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award for $5,574.98 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order to provide 4564767693 ! IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, with a period of performance through June 3, 2024. The contract is a Firm Fixed Price award with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,854.19 delivery order is for IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication. The contract has a firm fixed price and is set to expire on July 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,168.50 delivery order contract is for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,107.22 firm fixed-price delivery order is for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication, with a performance period through November 14, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (SPE2DB20D3101|SPE2DB24FRWG7) valued at $17,661.74. The contract is for the supply of Imitrex 6 mg/0.5 ml cartridges 0.5 ml to the Defense Logistics Agency (DLA), a defense agency. The award has an ultimate completion date of September 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $60,618.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication, and has an ultimate completion date of August 26, 2024. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML to the Defense Logistics Agency (DLA). The contract, which does not have a set-aside designation, is a Delivery Order with a Firm Fixed Price of $24,032.26 and an ultimate completion date of May 22, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $4,693.78 firm fixed price delivery order is for the provision of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML to support Department of Defense (DoD) healthcare programs. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
  • SPE2DB24D1006
    Indefinite Delivery Contract
  • SPE2DB24D1006-SPE2DB25FCDUQ
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML. The $1,549.58 Firm Fixed Price Delivery Order has an ultimate completion date of October 17, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.

Generated 1/15/25, 9:21 AM